ArticleInternational journal of hematology2026

Therapeutic drug monitoring guides personalized ponatinib dose reduction for chronic myeloid leukemia.

Maiko Abumiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.